Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biomea Fusion, Inc.

2.03
+0.08004.10%
Post-market: 2.030.00000.00%16:10 EDT
Volume:672.10K
Turnover:1.33M
Market Cap:120.80M
PE:-0.68
High:2.05
Open:1.97
Low:1.90
Close:1.95
52wk High:13.07
52wk Low:1.29
Shares:59.51M
Float Shares:48.85M
Volume Ratio:0.72
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9937
EPS(LYR):-3.8339
ROE:-170.54%
ROA:-68.73%
PB:4.39
PE(LYR):-0.53

Loading ...

Biomea Fusion: Promising Clinical Pipeline and Strategic Focus Drive Buy Rating

TIPRANKS
·
Sep 16

Biomea Fusion Inc - Phase I Trial for Bmf-650 in Obesity on Track With 28-Day Weight Loss Data Expected in Hy 2026

THOMSON REUTERS
·
Sep 16

Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and Provides Additional Corporate Update

GlobeNewswire
·
Sep 16

Biomea Fusion Initiated at Buy by Jefferies

Dow Jones
·
Aug 28

Biomea Fusion Inc : Jefferies Initiates Coverage With Buy Rating; Price Target $5

THOMSON REUTERS
·
Aug 28

Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Aug 06

Biomea Fusion Inc : Scotiabank Cuts Target Price to $10 From $30

THOMSON REUTERS
·
Aug 06

Biomea Fusion Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 06

Biomea Fusion Q2 net loss narrows to $20.7 mln

Reuters
·
Aug 06

BRIEF-Biomea Fusion Inc Files For Mixed Shelf Of Up To $300 Million – SEC Filing

Reuters
·
Aug 06

Biomea Fusion Q2 EPS $(0.51) Beats $(0.54) Estimate

Benzinga
·
Aug 06

Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights

GlobeNewswire
·
Aug 06

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 04

Biomea Fusion Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
Jul 30

Biomea Fusion Inc. Files Initial Statement of Beneficial Ownership for Director Julianne Averill

Reuters
·
Jul 25

Biomea Fusion Appoints Julianne Averill to Its Board of Directors

THOMSON REUTERS
·
Jul 24

Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jul 22

Biomea Fusion Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jun 24

Biomea Fusion Inc. Unveils Promising Data for Icovamenib, Showcasing Enhanced Glycemic Control and Weight Loss in Type 2 Diabetes Trial at ADA 2025

Reuters
·
Jun 23

Biomea Fusion Inc. Files Prospectus for $37.1 Million Underwritten Offering of Common Stock and Warrants

Reuters
·
Jun 21